Pharmaceutical - USA, Pricing

Filter

Current filters:

USAPricing

Popular Filters

AARP prescription drug Price Watch report shows cost of medicines vastly outpacing rate of inflation

AARP prescription drug Price Watch report shows cost of medicines vastly outpacing rate of inflation

24-11-2014

The latest Rx Price Watch Report from the American Association of Retired Persons (AARP) has found that…

Business FinanceHealthPharmaceuticalPharmaceutical sciencesPharmacologyPricingUSA

Cancer care is advancing, but costs cannot be ignored, says UnitedHealthcare SVP

Cancer care is advancing, but costs cannot be ignored, says UnitedHealthcare SVP

09-10-2014

Cancer care is advancing, but policymakers and the cancer care community must find ways to make it more…

HealthcareOncologyPharmaceuticalPricingUSA

Top 100 US drug pricing average jumps seven-fold to $9,400 in 2014

Top 100 US drug pricing average jumps seven-fold to $9,400 in 2014

26-09-2014

The median price of the top 100 drugs has skyrocketed from $1,260 in 2010 to $9,400 in 2014, representing…

PharmaceuticalPharmacologyPricingUnited StatesUSA

Curious resilience of the $50,000-per-QALY threshold

28-08-2014

For more than two decades, the ratio of $50,000 per quality-adjusted life-year (QALY) gained by using…

HealthcarePharmaceuticalPricingRegulationUSA

USIBC concludes successful pharmaceutical mission to India

USIBC concludes successful pharmaceutical mission to India

28-08-2014

The US-India Business Council (USIBC) has concluded its Pharmaceutical Executive Mission to Delhi, India.…

IndiaPatentsPharmaceuticalPricingUSA

PhRMA comments on Medicare Rights Center paper

25-07-2014

“Finding viable solutions to contain Medicare costs is critically important, but imposing price controls…

FinancialHealthcarePharmaceuticalPricingUSA

Expensive new hepatitis C drugs are worth the investment

Expensive new hepatitis C drugs are worth the investment

21-07-2014

The debate over the high price of new Hepatitis C Virus (HCV) drugs has focused on the price per pill,…

Anti-viralsCVS CaremarkGilead SciencesHepatitis CPharmaceuticalPricingSovaldiUSA

Orphan drug approvals rise, but high costs pose challenges for patients

Orphan drug approvals rise, but high costs pose challenges for patients

10-07-2014

Although the pace of approvals for new orphan drugs - medicines that treat relatively rare conditions…

EuropePharmaceuticalPricingRare diseasesRegulationUSA

Large increase seen in insulin use, out-of-pocket costs for type 2 diabetes

11-06-2014

Largely attributable to the widespread adoption of insulin analogs, use of insulin among patients with…

DiabetesHealthcarePharmaceuticalPricingUSA

PhRMA chief defends US prescription drug costs and value

PhRMA chief defends US prescription drug costs and value

30-05-2014

The head of the US trade group Pharmaceutical Research and Manufacturers of America has issued a strong…

HealthcarePharmaceuticalPricingUSA

Global pharma has significant opportunities for deeper engagement with payers but contingent on restoring trust

09-05-2014

New survey research finds that the majority payers in the USA and Europe believe that drug adherence…

EuropeManagementMarkets & MarketingPharmaceuticalPricingUSA

Express Scripts forecasts unsustainable increases in specialty drug spend in USA

Express Scripts forecasts unsustainable increases in specialty drug spend in USA

09-04-2014

Expensive treatments for broad patient populations are driving unprecedented growth in US spending on…

Anti-Arthritics/RheumaticsAnti-viralsMarkets & MarketingNorth AmericaOncologyPharmaceuticalPricingUSA

Patent lawyer seeking US Senate seat proposes patent reform to lower Rx drug costs

25-03-2014

Republican Art Gardner, a patent attorney seeking election to the US Senate in Georgia, has issued a…

North AmericaPatentsPharmaceuticalPoliticsPricingUSA

Back to top